Pharmacokinetics and Pharmacodynamics of Lansoprazole in Children 13 to 24 Months Old With Gastroesophageal Reflux Disease
Melvin B. Heyman(University of California, San Francisco), Harland S. Winter(Massachusetts General Hospital), Weijiang Zhang(Lake Forest College), Bidan Huang(AbbVie (United States)), Yi‐Lin Chiu(National Defense University), Fouad Amer(Lake Forest College)
Journal of Pediatric Gastroenterology and Nutrition
January 1, 2007
Cited by 9
Related Papers
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
|Cell Host & Microbe|2014|3.3k
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease
|Journal of Crohn s and Colitis|2014|1.1k
Induction and Maintenance Infliximab Therapy for the Treatment of Moderate-to-Severe Crohn’s Disease in Children
|Gastroenterology|2006|872